Related Experiment Video

Updated: Aug 11, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

Clinical trial considerations for pediatric cancer drug development

Freda Cooner1, Jingjing Ye2, Gregory Reaman3

  • 1Global Biostatistics, Amgen Inc, Thousand Oaks, CA, USA.

Journal of Biopharmaceutical Statistics
|February 7, 2023
PubMed

Insights

The RACE for Children Act now requires pediatric studies for certain adult cancer drugs. This aims to address the disparity in approved oncology treatments for pediatric cancer patients.

Area of Science:

  • Pediatric Oncology
  • Drug Development
  • Regulatory Science

Background:

  • Significant disparity exists in approved oncology drugs for pediatric versus adult cancer patients.
  • Historically, orphan drug designations exempted many oncology drugs from pediatric study requirements under the Pediatric Research Equity Act (PREA).

Purpose of the Study:

  • To discuss the implications of the RACE for Children Act on pediatric oncology drug development.
  • To outline considerations for clinical trial designs and statistical methodologies in pediatric cancer programs.

Main Methods:

  • Review of the legislative changes introduced by the RACE for Children Act.
  • Discussion of regulatory requirements for pediatric investigations in oncology.
  • Exploration of clinical trial design and statistical methodology adaptations.

Main Results:

  • The RACE for Children Act mandates pediatric investigations for specific adult cancer drugs targeting molecular pathways relevant to pediatric cancers.
  • This legislation aims to increase the number of approved treatments for pediatric cancer.

Conclusions:

  • The RACE for Children Act represents a significant shift in pediatric oncology drug development.
  • Careful consideration of clinical trial design and statistical methods is crucial for successful pediatric oncology programs under the new regulations.
Keywords:
RACE Actpediatric clinical programs

More Related Videos

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

3.2K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
155
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K